DJ Gilead Sciences Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) slid 2.14% to $145.68 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,711.76 and Dow Jones Industrial Average falling 0.02% to 53,559.99.
Gilead Sciences Inc. closed 7.38% short of its 52-week high of $157.29, which the company achieved on February 11th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.85% to $268.04, Pfizer Inc. $(PFE)$ fell 0.21% to $27.96, and Abbott Laboratories $(ABT)$ rose 0.79% to $112.47.
Trading volume (3.9 M) remained 3.2 million below its 50-day average volume of 7.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.
Comments